S. 2113 · 112th Congress
Transforming the Regulatory Environment to Accelerate Access to Treatments
- Stage
- In committee
- Sponsor
- Kay Hagan
- Introduced
- 2012-02-15
- Latest action
- 2012-02-15 · Introduced in Senate
Subjects
Executive agency funding and structure
Administrative law and regulatory procedures
Congressional oversight
Health
Health information and medical records
Advisory bodies
Department of Health and Human Services
Health technology, devices, supplies
Government ethics and transparency, public corruption
Federal officials
Government information and archives
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)